Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

ClinicalTrials.gov ID: NCT05327114

Public ClinicalTrials.gov record NCT05327114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 23, 2026, 6:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study identification

NCT ID: NCT05327114
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 201 participants

Conditions and interventions

Conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Interventions

Nipocalimab Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 22, 2022
Primary completion: May 13, 2027
Completion: Jun 17, 2029
Last update posted: Apr 12, 2026

2022 – 2029

United States locations

U.S. sites: 14
U.S. states: 12
U.S. cities: 14

Facility	City	State	ZIP	Site status
IMMUNOe Health and Research Centers	Centennial	Colorado	80112	Recruiting
Healthcare Innovations Institute Inc	Coral Springs	Florida	33067	Recruiting
Neurology Associates PA	Maitland	Florida	32751	Completed
University of Kansas Medical Center	Kansas City	Kansas	66160	Recruiting
Johns Hopkins Hospital	Baltimore	Maryland	21287	Recruiting
Boston Clinical Trials	Boston	Massachusetts	02111	Recruiting
Beaumont Hospital Royal Oak	Royal Oak	Michigan	48073	Completed
Kansas City Veterans Affairs Medical Center	Kansas City	Missouri	64128	Recruiting
The Neurological Institute of New York	New York	New York	10032	Completed
South Shore Neurologic Associates - Patchogue	Patchogue	New York	11772	Recruiting
The Neurological Institute, PA	Charlotte	North Carolina	28204	Recruiting
Cleveland Clinic Main Campus	Cleveland	Ohio	44195	Recruiting
Austin Neuromuscular Center	Austin	Texas	78756	Recruiting
Advocate Health - Aurora St. Luke's Medical Center	Milwaukee	Wisconsin	53215	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05327114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 12, 2026 · Synced Apr 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05327114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →